跳至主要内容
临床试验/NCT04700033
NCT04700033已完成不适用

Immersive Virtual Reality for Chronic Neuropathic Pain After Spinal Cord Injury: A Feasibility Trial

Icahn School of Medicine at Mount Sinai1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2019年7月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
23
试验地点
1
主要终点
Neuropathic Pain Symptom Inventory (NPSI)

研究概览

简要总结

The aim of this study is to provide critical information about the efficacy of Immersive Virtual Reality (IVR) to decrease the experience of neuropathic pain in the upper and lower extremities of people with a spinal cord injury.

详细描述

When a spinal cord injury occurs, the spinal somatosensory circuit is thought to generate aberrant nociceptive impulses that the brain interprets as pain. Neuropathic pain (NP) affects 40 to 70% of people with SCI and is a very disabling clinical condition. Many treatment options have been offered, but provide limited effects, leaving people with SCI with a reduced quality of life. The study team believes that Immersive Virtual Reality (IVR) neurorehabilitation has the potential to be an effective treatment for chronic neuropathic pain. For this reason, the objective of this study is to evaluate the feasibility of using a virtual reality device to decrease chronic neuropathic pain in individuals with spinal cord injury.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

盲法说明

Participant, PI and Outcome Assessor remain blinded for the entirety of the study.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Spinal cord injury survivors (chronic only)
  • Presence of neuropathic pain at or below SCI level for at least 6 months following trauma or disease of the spinal cord
  • A pain intensity of at least 2 out of 10 in the numerical pain rating scale (NPRS) test at baseline
  • Stable pharmacological treatment for at least 4 weeks prior to the study and throughout the trial

排除标准

  • Psychiatric or other neurological disorders (Participants will not be excluded for having a SCI, if they score 0-30 points on the BDI, or if they report having anxiety)
  • Head injuries causing cognitive or visual impairment
  • Severe vertigo

结局指标

主要结局

Neuropathic Pain Symptom Inventory (NPSI)

时间窗: Up to 10 Weeks

Neuropathic Pain Symptom Inventory (NPSI): This scale was developed to assess both the quantitative and qualitative qualities of neuropathic pain (NP). It includes 12 items, assessing spontaneous pain, brief attacks of pain, provoked pain and abnormal sensations in the painful area. This is a sensitive tool for measuring changes in neuropathic pain after a therapeutic intervention. Total score range for NPSI is 0-100, higher scores indicate more severity.

次要结局

  • Spinal Cord Independence Measure (SCIM III)(Up to 10 Weeks)
  • Immersive Tendencies Questionnaire (ITQ)(Up to 10 Weeks)
  • User Experience Score (UES)(14 Days)
  • Numerical Pain Rating Scale (NPRS)(16 Days)
  • Beck Depression Inventory (BDI)(Up to 10 Weeks)
  • Patient's Global Impression of Change (PGIC)(Up to 10 Weeks)
  • UQO- Presence Questionnaire (UPO-PQ)(16 Days)
  • Neuropathic Pain Scale (NPS)(Up to 10 Weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Putrino

Director of Rehabilitation Innovation

Icahn School of Medicine at Mount Sinai

研究点 (1)

Loading locations...

相似试验